Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) saw a significant drop in short interest during the month of October. As of October 30th, there was short interest totaling 7 shares, a drop of 99.7% from the October 15th total of 2,190 shares. Based on an average daily trading volume, of 12,811 shares, the days-to-cover ratio is presently 0.0 days.
Biofrontera Stock Performance
Shares of BFRIW stock opened at $0.00 on Wednesday. Biofrontera has a fifty-two week low of $0.00 and a fifty-two week high of $0.15. The stock’s 50-day simple moving average is $0.01 and its 200-day simple moving average is $0.03.
About Biofrontera
Biofrontera Inc. is a biopharmaceutical company focused on dermatology. It develops and commercializes treatments for sun-damaged skin and other conditions, with an emphasis on photodynamic therapy, which uses a light-sensitive medicine activated by a light source. Biofrontera Inc. became a separately traded U.S. company after its separation from Germany-based Biofrontera AG. BFRIW represents warrants associated with Biofrontera Inc., rather than the company’s common stock.
See Also
- Five stocks we like better than Biofrontera
- Anthropic’s Trillion-Dollar IPO Could Give Cloud Giants a Double Win
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
- The Trade Desk Beats on Revenue, But the Fine Print Matters
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
